Japan CINV Existing and Pipeline Drugs Market (2025-2031) | Competitive Landscape, Segmentation, Size & Revenue, Trends, Analysis, Industry, Outlook, Growth, Value, Share, Companies, Forecast

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Japan Country Macro Economic Indicators

3.2 Japan CINV Existing and Pipeline Drugs Market Revenues & Volume, 2021 & 2031F

3.3 Japan CINV Existing and Pipeline Drugs Market - Industry Life Cycle

3.4 Japan CINV Existing and Pipeline Drugs Market - Porter's Five Forces

3.5 Japan CINV Existing and Pipeline Drugs Market Revenues & Volume Share, By Major Drug, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chemotherapy-induced nausea and vomiting (CINV) cases in Japan

4.2.2 Growing adoption of advanced CINV drugs and therapies

4.2.3 Rising healthcare expenditure and government initiatives to improve cancer care in Japan

4.3 Market Restraints

4.3.1 Stringent regulations and approval processes for new drugs in Japan

4.3.2 High costs associated with developing and marketing CINV drugs

4.3.3 Competition from alternative therapies and treatments for CINV in the market

6.1 Japan CINV Existing and Pipeline Drugs Market, By Major Drug

6.1.1 Overview and Analysis

6.1.2 Japan CINV Existing and Pipeline Drugs Market Revenues & Volume, By Major Drug, 2021- 2031F

6.1.3 Japan CINV Existing and Pipeline Drugs Market Revenues & Volume, By Aloxi (Palonosetron), 2021- 2031F

6.1.4 Japan CINV Existing and Pipeline Drugs Market Revenues & Volume, By Zofran Generic (Ondansetron), 2021- 2031F

6.1.5 Japan CINV Existing and Pipeline Drugs Market Revenues & Volume, By Kytril Generic (Granisetron), 2021- 2031F

6.1.6 Japan CINV Existing and Pipeline Drugs Market Revenues & Volume, By Emend (Aprepitant), 2021- 2031F

6.1.7 Japan CINV Existing and Pipeline Drugs Market Revenues & Volume, By Akynzeo (Netupitant-Palonosetron), 2021- 2031F

6.1.8 Japan CINV Existing and Pipeline Drugs Market Revenues & Volume, By SUSTOL (Extended Release Granisetron Injection), 2021- 2031F

7.1 Japan CINV Existing and Pipeline Drugs Market Export to Major Countries

7.2 Japan CINV Existing and Pipeline Drugs Market Imports from Major Countries

8.1 Patient adherence rate to CINV treatments

8.2 Number of clinical trials for new CINV drugs in Japan

8.3 Rate of adoption of advanced CINV therapies by healthcare facilities in Japan

9.1 Japan CINV Existing and Pipeline Drugs Market Opportunity Assessment, By Major Drug, 2021 & 2031F

10.1 Japan CINV Existing and Pipeline Drugs Market Revenue Share, By Companies, 2024

10.2 Japan CINV Existing and Pipeline Drugs Market Competitive Benchmarking, By Operating and Technical Parameters